List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 11 studies with search of:   "Vical" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Pandemic Influenza Plasmid DNA Vaccines (Needle)
Condition: Influenza
Interventions: Biological: VCL-IPT1;   Biological: VCL-IPT1;   Biological: VCL-IPT1;   Biological: VCL-IPM1;   Biological: PBS
2 Completed Pandemic Influenza Plasmid DNA Vaccines (Needle-Free)
Condition: Influenza
Interventions: Biological: VCL-IPM1;   Biological: VCL-IPM1;   Biological: VCL-IPT1;   Biological: PBS
3 Completed Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma
Conditions: Stage IV Melanoma;   Stage III Melanoma;   Recurrent Melanoma
Intervention: Drug: allovectin-7
4 Completed Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma
Conditions: Stage IV Melanoma;   Stage III Melanoma;   Recurrent Melanoma
Interventions: Drug: allovectin-7;   Drug: allovectin-7/dacarbazine;   Drug: dacarbazine
5 Active, not recruiting Phase II Trial of Allovectin-7® for Metastatic Melanoma
Conditions: Melanoma;   Metastatic Melanoma;   Malignant Melanoma;   Skin Cancer
Intervention: Genetic: Allovectin-7®
6 Active, not recruiting Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)
Conditions: Acute Lymphoblastic Leukemia;   Chronic Myelogenous Leukemia;   Acute Myelogenous Leukemia;   Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma;   Myelodysplastic Syndrome
Interventions: Biological: VCL-CB01;   Other: PBS
7 Recruiting A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma
Condition: Metastatic Melanoma
Interventions: Biological: Allovectin-7®;   Drug: Dacarbazine (DTIC);   Drug: Temozolomide (TMZ)
8 Completed Phase II Trial of Allovectin-7® for Head and Neck Cancer
Conditions: Head and Neck Cancer;   Squamous Cell Carcinoma of the Oral Cavity or Oropharynx;   Head and Neck Neoplasms;   Carcinoma of the Head and Neck
Intervention: Genetic: Allovectin-7®
9 Active, not recruiting A Trial to Evaluate the Safety of Intratumoral VCL-IM01 Followed by Electroporation in Metastatic Melanoma
Condition: Metastatic Melanoma
Intervention: Genetic: VCL-IM01 (encoding IL-2) with Electroporation
10 Completed Phase 1 Trial of CMV Towne Vaccine in Subjects Previously Received VCL CT02 Vaccine ID or IM
Condition: Cytomegalovirus Infection
Intervention: Biological: Towne CMV vaccine
11 Completed Trial of pDNA CMV Vaccine (VCL-CT02) Followed by Towne CMV Vaccine (Towne) Challenge
Condition: Cytomegalovirus Infection
Interventions: Biological: VCL CT02 pDNA vaccine;   Biological: Towne CMV vaccine

  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services